UniProt ID | NFIC_HUMAN | |
---|---|---|
UniProt AC | P08651 | |
Protein Name | Nuclear factor 1 C-type | |
Gene Name | NFIC | |
Organism | Homo sapiens (Human). | |
Sequence Length | 508 | |
Subcellular Localization | Nucleus. | |
Protein Description | Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.. | |
Protein Sequence | MYSSPLCLTQDEFHPFIEALLPHVRAFAYTWFNLQARKRKYFKKHEKRMSKDEERAVKDELLGEKPEVKQKWASRLLAKLRKDIRPECREDFVLSITGKKAPGCVLSNPDQKGKMRRIDCLRQADKVWRLDLVMVILFKGIPLESTDGERLVKAAQCGHPVLCVQPHHIGVAVKELDLYLAYFVRERDAEQSGSPRTGMGSDQEDSKPITLDTTDFQESFVTSGVFSVTELIQVSRTPVVTGTGPNFSLGELQGHLAYDLNPASTGLRRTLPSTSSSGSKRHKSGSMEEDVDTSPGGDYYTSPSSPTSSSRNWTEDMEGGISSPVKKTEMDKSPFNSPSPQDSPRLSSFTQHHRPVIAVHSGIARSPHPSSALHFPTTSILPQTASTYFPHTAIRYPPHLNPQDPLKDLVSLACDPASQQPGPLNGSGQLKMPSHCLSAQMLAPPPPGLPRLALPPATKPATTSEGGATSPTSPSYSPPDTSPANRSFVGLGPRDPAGIYQAQSWYLG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MYSSPLCL -------CCCCCCCC | 7.08 | 20068231 | |
2 | Phosphorylation | ------MYSSPLCLT ------CCCCCCCCC | 20.18 | 28450419 | |
3 | Phosphorylation | -----MYSSPLCLTQ -----CCCCCCCCCC | 24.96 | 28450419 | |
4 | Phosphorylation | ----MYSSPLCLTQD ----CCCCCCCCCCC | 12.38 | 25159151 | |
9 | Phosphorylation | YSSPLCLTQDEFHPF CCCCCCCCCCHHHHH | 32.74 | 28450419 | |
41 | Phosphorylation | LQARKRKYFKKHEKR HHHHHHHHHHHHHHH | 25.35 | 22817900 | |
50 | Phosphorylation | KKHEKRMSKDEERAV HHHHHHCCHHHHHHH | 40.77 | 20068231 | |
58 | Acetylation | KDEERAVKDELLGEK HHHHHHHHHHHCCCC | 44.49 | 26051181 | |
58 | Ubiquitination | KDEERAVKDELLGEK HHHHHHHHHHHCCCC | 44.49 | - | |
65 | Acetylation | KDELLGEKPEVKQKW HHHHCCCCHHHHHHH | 44.68 | 26051181 | |
65 | Ubiquitination | KDELLGEKPEVKQKW HHHHCCCCHHHHHHH | 44.68 | - | |
99 | Ubiquitination | FVLSITGKKAPGCVL CEEEEECCCCCCCCC | 36.79 | - | |
112 | Ubiquitination | VLSNPDQKGKMRRID CCCCCCCCCCCCHHH | 68.80 | - | |
146 | Phosphorylation | KGIPLESTDGERLVK CCCCCCCCCHHHHHH | 38.35 | - | |
192 | Phosphorylation | RERDAEQSGSPRTGM HHHCHHHCCCCCCCC | 32.51 | 30266825 | |
194 | Phosphorylation | RDAEQSGSPRTGMGS HCHHHCCCCCCCCCC | 19.22 | 30266825 | |
194 (in isoform 5) | Phosphorylation | - | 19.22 | 24719451 | |
197 | Phosphorylation | EQSGSPRTGMGSDQE HHCCCCCCCCCCCCC | 34.60 | 24275569 | |
201 | Phosphorylation | SPRTGMGSDQEDSKP CCCCCCCCCCCCCCC | 27.51 | 28102081 | |
206 | Phosphorylation | MGSDQEDSKPITLDT CCCCCCCCCCEEEEC | 39.31 | 28102081 | |
237 | Phosphorylation | ELIQVSRTPVVTGTG HEEEEECCCEEECCC | 16.96 | 20068231 | |
241 | Phosphorylation | VSRTPVVTGTGPNFS EECCCEEECCCCCCC | 29.29 | 20068231 | |
243 | Phosphorylation | RTPVVTGTGPNFSLG CCCEEECCCCCCCHH | 39.85 | 23663014 | |
248 | Phosphorylation | TGTGPNFSLGELQGH ECCCCCCCHHHHCCE | 41.95 | 23663014 | |
258 | Phosphorylation | ELQGHLAYDLNPAST HHCCEEEECCCHHCC | 27.59 | 23663014 | |
264 | Phosphorylation | AYDLNPASTGLRRTL EECCCHHCCCHHHCC | 25.02 | 25159151 | |
264 (in isoform 5) | Phosphorylation | - | 25.02 | 24719451 | |
265 | Phosphorylation | YDLNPASTGLRRTLP ECCCHHCCCHHHCCC | 42.20 | 28348404 | |
270 | Phosphorylation | ASTGLRRTLPSTSSS HCCCHHHCCCCCCCC | 36.26 | 28152594 | |
273 | Phosphorylation | GLRRTLPSTSSSGSK CHHHCCCCCCCCCCC | 43.99 | 21955146 | |
273 (in isoform 5) | Phosphorylation | - | 43.99 | 24719451 | |
274 | Phosphorylation | LRRTLPSTSSSGSKR HHHCCCCCCCCCCCC | 30.59 | 28152594 | |
275 | O-linked_Glycosylation | RRTLPSTSSSGSKRH HHCCCCCCCCCCCCC | 27.18 | 30059200 | |
275 | Phosphorylation | RRTLPSTSSSGSKRH HHCCCCCCCCCCCCC | 27.18 | 25159151 | |
276 | Phosphorylation | RTLPSTSSSGSKRHK HCCCCCCCCCCCCCC | 38.51 | 23401153 | |
277 | Phosphorylation | TLPSTSSSGSKRHKS CCCCCCCCCCCCCCC | 47.02 | 25159151 | |
279 | Phosphorylation | PSTSSSGSKRHKSGS CCCCCCCCCCCCCCC | 28.59 | 25159151 | |
280 | Acetylation | STSSSGSKRHKSGSM CCCCCCCCCCCCCCC | 63.15 | 26051181 | |
284 | Phosphorylation | SGSKRHKSGSMEEDV CCCCCCCCCCCCCCC | 29.94 | 23927012 | |
284 (in isoform 5) | Phosphorylation | - | 29.94 | 24719451 | |
286 | Phosphorylation | SKRHKSGSMEEDVDT CCCCCCCCCCCCCCC | 30.06 | 23927012 | |
286 (in isoform 5) | Phosphorylation | - | 30.06 | 24719451 | |
293 | Phosphorylation | SMEEDVDTSPGGDYY CCCCCCCCCCCCCCC | 36.35 | 30278072 | |
293 (in isoform 5) | Phosphorylation | - | 36.35 | 24719451 | |
294 | Phosphorylation | MEEDVDTSPGGDYYT CCCCCCCCCCCCCCC | 19.65 | 23927012 | |
294 (in isoform 5) | Phosphorylation | - | 19.65 | 24719451 | |
299 | Phosphorylation | DTSPGGDYYTSPSSP CCCCCCCCCCCCCCC | 16.36 | 30278072 | |
300 | Phosphorylation | TSPGGDYYTSPSSPT CCCCCCCCCCCCCCC | 12.89 | 23927012 | |
301 | Phosphorylation | SPGGDYYTSPSSPTS CCCCCCCCCCCCCCC | 28.12 | 23927012 | |
302 | Phosphorylation | PGGDYYTSPSSPTSS CCCCCCCCCCCCCCC | 13.48 | 23927012 | |
304 | Phosphorylation | GDYYTSPSSPTSSSR CCCCCCCCCCCCCCC | 49.03 | 23401153 | |
304 (in isoform 5) | Phosphorylation | - | 49.03 | 24719451 | |
305 | Phosphorylation | DYYTSPSSPTSSSRN CCCCCCCCCCCCCCC | 35.26 | 23927012 | |
307 | Phosphorylation | YTSPSSPTSSSRNWT CCCCCCCCCCCCCCC | 43.09 | 30278072 | |
308 | Phosphorylation | TSPSSPTSSSRNWTE CCCCCCCCCCCCCCC | 29.69 | 30278072 | |
309 | Phosphorylation | SPSSPTSSSRNWTED CCCCCCCCCCCCCCC | 35.48 | 30278072 | |
310 | Phosphorylation | PSSPTSSSRNWTEDM CCCCCCCCCCCCCCC | 29.42 | 30278072 | |
314 | Phosphorylation | TSSSRNWTEDMEGGI CCCCCCCCCCCCCCC | 26.17 | 22167270 | |
322 | Phosphorylation | EDMEGGISSPVKKTE CCCCCCCCCCCCCCC | 31.68 | 22167270 | |
323 | Phosphorylation | DMEGGISSPVKKTEM CCCCCCCCCCCCCCC | 31.62 | 22167270 | |
323 (in isoform 5) | Phosphorylation | - | 31.62 | 24719451 | |
328 | Phosphorylation | ISSPVKKTEMDKSPF CCCCCCCCCCCCCCC | 30.72 | 30266825 | |
333 | Phosphorylation | KKTEMDKSPFNSPSP CCCCCCCCCCCCCCC | 30.38 | 29255136 | |
337 | Phosphorylation | MDKSPFNSPSPQDSP CCCCCCCCCCCCCCC | 27.43 | 29255136 | |
339 | Phosphorylation | KSPFNSPSPQDSPRL CCCCCCCCCCCCCCH | 34.71 | 29255136 | |
339 (in isoform 5) | Phosphorylation | - | 34.71 | 24719451 | |
343 | Phosphorylation | NSPSPQDSPRLSSFT CCCCCCCCCCHHHHH | 13.48 | 29255136 | |
343 (in isoform 5) | Phosphorylation | - | 13.48 | 24719451 | |
345 | Methylation | PSPQDSPRLSSFTQH CCCCCCCCHHHHHHC | 51.67 | 115384105 | |
347 | Phosphorylation | PQDSPRLSSFTQHHR CCCCCCHHHHHHCCC | 25.37 | 27251275 | |
348 | Phosphorylation | QDSPRLSSFTQHHRP CCCCCHHHHHHCCCC | 36.58 | 23401153 | |
348 (in isoform 5) | Phosphorylation | - | 36.58 | 24719451 | |
350 | Phosphorylation | SPRLSSFTQHHRPVI CCCHHHHHHCCCCEE | 29.01 | 28348404 | |
361 | Phosphorylation | RPVIAVHSGIARSPH CCEEEEECCCCCCCC | 25.87 | 23312004 | |
365 | Asymmetric dimethylarginine | AVHSGIARSPHPSSA EEECCCCCCCCCCCC | 49.12 | - | |
365 | Methylation | AVHSGIARSPHPSSA EEECCCCCCCCCCCC | 49.12 | 24129315 | |
366 | Phosphorylation | VHSGIARSPHPSSAL EECCCCCCCCCCCCC | 20.66 | 25159151 | |
370 | Phosphorylation | IARSPHPSSALHFPT CCCCCCCCCCCCCCC | 25.80 | 28152594 | |
371 | Phosphorylation | ARSPHPSSALHFPTT CCCCCCCCCCCCCCC | 39.02 | 28152594 | |
377 | Phosphorylation | SSALHFPTTSILPQT CCCCCCCCCCCCCCC | 32.03 | 28450419 | |
378 | Phosphorylation | SALHFPTTSILPQTA CCCCCCCCCCCCCCC | 17.63 | 28450419 | |
379 | Phosphorylation | ALHFPTTSILPQTAS CCCCCCCCCCCCCCC | 25.30 | 28450419 | |
395 | Asymmetric dimethylarginine | YFPHTAIRYPPHLNP CCCCCCCCCCCCCCC | 35.13 | - | |
395 | Methylation | YFPHTAIRYPPHLNP CCCCCCCCCCCCCCC | 35.13 | 24129315 | |
396 | Phosphorylation | FPHTAIRYPPHLNPQ CCCCCCCCCCCCCCC | 18.27 | 29632367 | |
427 | Phosphorylation | QPGPLNGSGQLKMPS CCCCCCCCCCCCCCH | 23.46 | 20886841 | |
434 | Phosphorylation | SGQLKMPSHCLSAQM CCCCCCCHHHEEHHH | 24.27 | 23186163 | |
438 | Phosphorylation | KMPSHCLSAQMLAPP CCCHHHEEHHHCCCC | 23.11 | 23917254 | |
451 | Methylation | PPPPGLPRLALPPAT CCCCCCCCCCCCCCC | 37.32 | 24129315 | |
458 | Phosphorylation | RLALPPATKPATTSE CCCCCCCCCCCCCCC | 43.25 | 23186163 | |
459 | Acetylation | LALPPATKPATTSEG CCCCCCCCCCCCCCC | 34.46 | 26051181 | |
460 (in isoform 2) | Phosphorylation | - | 30.40 | 24719451 | |
462 | Phosphorylation | PPATKPATTSEGGAT CCCCCCCCCCCCCCC | 39.11 | 25850435 | |
463 | Phosphorylation | PATKPATTSEGGATS CCCCCCCCCCCCCCC | 27.21 | 25850435 | |
463 (in isoform 2) | Phosphorylation | - | 27.21 | 24719451 | |
464 | Phosphorylation | ATKPATTSEGGATSP CCCCCCCCCCCCCCC | 29.86 | 25850435 | |
464 (in isoform 2) | Phosphorylation | - | 29.86 | 24719451 | |
469 | Phosphorylation | TTSEGGATSPTSPSY CCCCCCCCCCCCCCC | 38.21 | 26657352 | |
470 | Phosphorylation | TSEGGATSPTSPSYS CCCCCCCCCCCCCCC | 26.16 | 30576142 | |
472 | Phosphorylation | EGGATSPTSPSYSPP CCCCCCCCCCCCCCC | 53.70 | 25159151 | |
473 | Phosphorylation | GGATSPTSPSYSPPD CCCCCCCCCCCCCCC | 18.42 | 25159151 | |
475 | Phosphorylation | ATSPTSPSYSPPDTS CCCCCCCCCCCCCCC | 37.70 | 25850435 | |
476 | Phosphorylation | TSPTSPSYSPPDTSP CCCCCCCCCCCCCCC | 28.69 | 29116813 | |
477 | Phosphorylation | SPTSPSYSPPDTSPA CCCCCCCCCCCCCCC | 34.00 | 25850435 | |
481 | Phosphorylation | PSYSPPDTSPANRSF CCCCCCCCCCCCCCC | 42.24 | 24275569 | |
482 | Phosphorylation | SYSPPDTSPANRSFV CCCCCCCCCCCCCCC | 29.42 | 27732954 | |
487 | Phosphorylation | DTSPANRSFVGLGPR CCCCCCCCCCCCCCC | 24.88 | 8710515 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NFIC_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NFIC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NFIC_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LLPH_HUMAN | LLPH | physical | 16189514 | |
TPD55_HUMAN | TPD52L3 | physical | 16189514 | |
ZCH14_HUMAN | ZCCHC14 | physical | 16189514 | |
ZKSC7_HUMAN | ZKSCAN7 | physical | 16189514 | |
TKTL2_HUMAN | TKTL2 | physical | 16189514 | |
SMAD3_HUMAN | SMAD3 | physical | 22195013 | |
SMUF1_HUMAN | SMURF1 | physical | 22195013 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294; SER-305; SER-323;SER-333 AND SER-339, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304; SER-305; SER-339AND SER-343, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323 AND SER-339, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-194; SER-323;SER-333 AND SER-339, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194; SER-333 ANDSER-339, AND MASS SPECTROMETRY. |